-- 加拿大皇家銀行資本市場（RBC Capital Markets）週一發布的研究報告指出，由於多重不利因素，GitLab (GTLB) 股價將維持區間震盪，短期內上漲空間有限。 分析師表示，這些挑戰包括：難以與同類產品進行比較、首單銷售轉型風險、企業裁員加劇、地緣政治動盪以及競爭對手的擔憂。 報告指出，儘管 GitLab 作為 DeVSecOps 平台的長期發展前景廣闊，且 Duo Agent 平台可能成為中期成長的催化劑，但短期內對績效貢獻不大。 RBC 將該股評級從“跑贏大盤”下調至“與行業持平”，並將目標股價從每股 33 美元下調至 25 美元。
Price: $21.33, Change: $-0.09, Percent Change: -0.42%
Axcelis Technologies (ACLS) shares were up 8.6% in afternoon trading on Monday after B. Riley upgraded the company's stock to buy from neutral and raised the price target to $150 from $91.Trading volume stood at around 809,000 shares, roughly the same number as the stock's daily average.Price: $128.52, Change: $+9.79, Percent Change: +8.25%
Abbott Laboratories (ABT) has an average rating of overweight and mean price target of $120.48, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $96.06, Change: $-0.75, Percent Change: -0.77%
NevGold (NAU.V) on Monday said it is upsizing best-efforts private placement of shares to $42.2 million, up from its original $25-million target.The company said it will now look to place 22.2 million shares priced of C$1.90 each.The company plans to use proceeds for advancing its Limousine Butte antimony-gold project in Nevada, the Nutmeg Mountain gold project in Idaho, and for working capital and general corporate purposes.The company's shares were last seen up $0.04 to $2.14 on the TSX Venture Exchange.Price: $2.16, Change: $+0.06, Percent Change: +2.86%